Skip to main content

Chronic Pain News (Page 3)

Women in Military More Likely to Suffer Chronic Pain During Wartime

MONDAY, July 8, 2024 – Wartime appears to increase the risk of chronic pain for military women, a new study suggests. Active-duty servicewomen who served between 2006 and 2013 – a period of h...

FDA Approves Arymo ER (morphine sulfate) Abuse-Deterrent Formulation for the Treatment of Chronic Pain

WAYNE, Penn., Jan. 9, 2017 /PRNewswire/ – Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing...

FDA Approves Belbuca (buprenorphine) Buccal Film for Chronic Pain Management

DUBLIN and RALEIGH, N.C., October 26, 2015 – Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI),...

FDA Approves Targiniq ER Extended-Release Oxycodone with Abuse-Deterrent Properties

July 23, 2014 – Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Pain

Related drug support groups

tramadol, gabapentin, Cymbalta, oxycodone, ibuprofen, hydrocodone, naproxen, acetaminophen, amitriptyline, view more... Percocet, pregabalin, duloxetine, diclofenac, methadone, codeine, OxyContin, fentanyl, morphine, buprenorphine, nortriptyline, Butrans, Dilaudid, Roxicodone, Percocet 10/325, hydromorphone, Belbuca